House Over­sight Com­mit­tee opens probe in­to FDA's han­dling of drug short­ages

Re­pub­li­can rep­re­sen­ta­tives lead­ing the House Com­mit­tee on Over­sight and Ac­count­abil­i­ty to­day an­nounced an in­ves­ti­ga­tion in­to FDA’s re­sponse to crit­i­cal US drug short­ages, in­clud­ing com­mon can­cer …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER